Literature DB >> 27856649

The Barrel stent: new treatment option for stent-assisted coiling of wide-necked bifurcation aneurysms-results of a single-center study.

Ruben Mühl-Benninghaus1, Andreas Simgen1, Wolfgang Reith1, Umut Yilmaz1.   

Abstract

PURPOSE: The Barrel stent is a laser cut stent designed for stent-assisted coil embolization of wide-necked bifurcation or branch aneurysms with a single device, with the purpose of lowering the metal-to-artery ratio and its inherent risk of thromboembolic complications of multiple stents. We report our early experiences with this device in 17 patients in this retrospective single-center analysis.
MATERIALS AND METHODS: 17 consecutive patients who underwent stent-assisted coil embolization of wide-necked bifurcation aneurysms with the Barrel stent were retrospectively identified. We analyzed the feasibility of successful deployment and post-treatment angiographic results. Adverse events, clinical outcome, and angiographic follow-up results were also analyzed.
RESULTS: Aneurysms were located in the internal carotid artery (n=3), the middle cerebral artery (n=9), the anterior communicating artery (n=3), and the basilar artery (n=2). In the immediate post-treatment angiography, adequate occlusion (neck remnant or total occlusion) was observed in 16/17 (94.1%) of aneurysms. One patient experienced a transient ischemic attack. No permanent neurologic deficits were observed. 13/17 (76.5%) patients underwent short-term follow-up angiography after 3 months, all of which showed adequate occlusion of the aneurysm.
CONCLUSIONS: In this small retrospective single-center analysis we show that stent-assisted coiling with the Barrel stent is a safe and effective option for the endovascular treatment of intracranial wide-necked bifurcation aneurysms. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Aneurysm; Angioplasty; Coil; Device; Stent

Mesh:

Year:  2016        PMID: 27856649     DOI: 10.1136/neurintsurg-2016-012718

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  6 in total

1.  Stent-assisted coiling of wide-neck bifurcation aneurysms with a branch incorporated in the aneurysm base: long-term follow-up in 49 patients with 53 aneurysms.

Authors:  Boris Lubicz; Ricardo Morais; Pierre-Julien Bruyère; Noémie Ligot; Benjamin Mine
Journal:  Neuroradiology       Date:  2017-04-11       Impact factor: 2.804

2.  In Vitro Evaluation of Fusiform-Shaped Stents for Wide-Neck Intracranial Aneurysm Treatment.

Authors:  Zhen Yu Jia; Yuan Yuan Jiang; Jung Min Woo; Seon Moon Hwang; Ok Kyun Lim; Tae Il Kim; Jung Cheol Park; Hee Sun Lee; Eun Sang Kim; Deok Hee Lee
Journal:  Neurointervention       Date:  2018-08-31

Review 3.  Leo stent for endovascular treatment of intracranial aneurysms: very long-term results in 50 patients with 52 aneurysms and literature review.

Authors:  Boris Lubicz; Alexandre Kadou; Ricardo Morais; Benjamin Mine
Journal:  Neuroradiology       Date:  2017-03-01       Impact factor: 2.804

4.  Long-term follow-up of the pCONus device for the treatment of wide-neck bifurcation aneurysms.

Authors:  Adrien Guenego; Benjamin Mine; Thomas Bonnet; Stephanie Elens; Juan Vazquez Suarez; Lise Jodaitis; Noémie Ligot; Gilles Naeije; Boris Lubicz
Journal:  Interv Neuroradiol       Date:  2021-09-13       Impact factor: 1.764

5.  Analysis of branch artery orifice angulation: Feasibility of the shelf technique for the treatment of wide-neck bifurcation aneurysms.

Authors:  Mehmet Onay; Ali Burak Binboga; Cetin Murat Altay
Journal:  Interv Neuroradiol       Date:  2020-11-22       Impact factor: 1.764

Review 6.  Development of New Endovascular Devices for Aneurysm Treatment.

Authors:  Zhen Yu Jia; Hai Bin Shi; Shigeru Miyachi; Sun Moon Hwang; Jae Jon Sheen; Yun Sun Song; Joong Goo Kim; Deok Hee Lee; Dae Chul Suh
Journal:  J Stroke       Date:  2018-01-31       Impact factor: 6.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.